140 related articles for article (PubMed ID: 34920100)
1. Novel X gene point mutations in chronic hepatitis B and HBV related cirrhotic patients.
Salarnia F; Behboudi E; Shahramian I; Moradi A
Infect Genet Evol; 2022 Jan; 97():105186. PubMed ID: 34920100
[TBL] [Abstract][Full Text] [Related]
2. Impact of hepatitis B virus (HBV) x gene mutations on hepatocellular carcinoma development in chronic HBV infection.
Lee JH; Han KH; Lee JM; Park JH; Kim HS
Clin Vaccine Immunol; 2011 Jun; 18(6):914-21. PubMed ID: 21490166
[TBL] [Abstract][Full Text] [Related]
3. Naturally occurring basal core promoter A1762T/G1764A dual mutations increase the risk of HBV-related hepatocellular carcinoma: a meta-analysis.
Yang Z; Zhuang L; Lu Y; Xu Q; Tang B; Chen X
Oncotarget; 2016 Mar; 7(11):12525-36. PubMed ID: 26848866
[TBL] [Abstract][Full Text] [Related]
4. Specific mutations in the enhancer II/core promoter/precore regions of hepatitis B virus subgenotype C2 in Korean patients with hepatocellular carcinoma.
Kim JK; Chang HY; Lee JM; Baatarkhuu O; Yoon YJ; Park JY; Kim DY; Han KH; Chon CY; Ahn SH
J Med Virol; 2009 Jun; 81(6):1002-8. PubMed ID: 19382267
[TBL] [Abstract][Full Text] [Related]
5. HBx M130K and V131I (T-A) mutations in HBV genotype F during a follow-up study in chronic carriers.
León B; Taylor L; Vargas M; Luftig RB; Albertazzi F; Herrero L; Visona K
Virol J; 2005 Aug; 2():60. PubMed ID: 16080797
[TBL] [Abstract][Full Text] [Related]
6. The Effect of ICOS Polymorphism Interactions with HBV Mutations on HBV Subtype Infection Outcomes.
Song XM; Li QL; Guo F; Peng H; Guo JJ
Ann Hepatol; 2018 Oct; 17(6):940-947. PubMed ID: 30600290
[TBL] [Abstract][Full Text] [Related]
7. The novel HBx mutation F30V correlates with hepatocellular carcinoma in vivo, reduces hepatitis B virus replicative efficiency and enhances anti-apoptotic activity of HBx N terminus in vitro.
Salpini R; Surdo M; Cortese MF; Palumbo GA; Carioti L; Cappiello G; Spanò A; Trimoulet P; Fleury H; Vecchiet J; Pasquazzi C; Mirabelli C; Scutari R; Sacco A; Alkhatib M; Missale G; Francioso S; Sarmati L; Andreoni M; Angelico M; Ceccherini-Silberstein F; Levrero M; Perno CF; Belloni L; Svicher V
Clin Microbiol Infect; 2019 Jul; 25(7):906.e1-906.e7. PubMed ID: 30472417
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of the relationship between hepatitis B virus precore and basal core promoter mutations and acute-on-chronic liver failure].
Ma XY; Han T; Pei YZ; Zhao ZG; Gao YT; Li Y; Jing L
Zhonghua Gan Zang Bing Za Zhi; 2012 Sep; 20(9):644-8. PubMed ID: 23207226
[TBL] [Abstract][Full Text] [Related]
9. Core promoter mutation of nucleotides A1762T and G1764A of hepatitis B virus increases core promoter transactivation by hepatocyte nuclear factor 1.
Seong MS; Hwang HJ; Jang EA; Jang JA; Aung WW; Kyaw YY; Cheong J
J Microbiol; 2022 Oct; 60(10):1039-1047. PubMed ID: 36167927
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of the mutations in basal core promoter of hepatitis B virus subgenotype C1 increase the risk of hepatocellular carcinoma in Southern China.
Li W; Chen G; Yu X; Shi Y; Peng M; Wei J
Int J Clin Exp Pathol; 2013; 6(6):1076-85. PubMed ID: 23696925
[TBL] [Abstract][Full Text] [Related]
11. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma: a meta-analysis.
Liu S; Zhang H; Gu C; Yin J; He Y; Xie J; Cao G
J Natl Cancer Inst; 2009 Aug; 101(15):1066-82. PubMed ID: 19574418
[TBL] [Abstract][Full Text] [Related]
12. Genomic change in hepatitis B virus associated with development of hepatocellular carcinoma.
Lee D; Lyu H; Chung YH; Kim JA; Mathews P; Jaffee E; Zheng L; Yu E; Lee YJ; Ryu SH
World J Gastroenterol; 2016 Jun; 22(23):5393-9. PubMed ID: 27340355
[TBL] [Abstract][Full Text] [Related]
13. Combinations of eight key mutations in the X/preC region and genomic activity of hepatitis B virus are associated with hepatocellular carcinoma.
Park YM; Jang JW; Yoo SH; Kim SH; Oh IM; Park SJ; Jang YS; Lee SJ
J Viral Hepat; 2014 Mar; 21(3):171-7. PubMed ID: 24344773
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus X protein: The X factor in chronic hepatitis B virus disease progression.
Mani M; Vijayaraghavan S; Sarangan G; Barani R; Abraham P; Srikanth P
Indian J Med Microbiol; 2019; 37(3):387-392. PubMed ID: 32003338
[TBL] [Abstract][Full Text] [Related]
15. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
Guo X; Jin Y; Qian G; Tu H
J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus basal core promoter/precore mutants and association with liver cirrhosis in children with chronic hepatitis B virus infection.
Zhong YW; Di FL; Liu C; Zhang XC; Bi JF; Li YL; Wu SQ; Dong H; Liu LM; He J; Shi YM; Zhang HF; Zhang M
Clin Microbiol Infect; 2016 Apr; 22(4):379.e1-379.e8. PubMed ID: 26577140
[TBL] [Abstract][Full Text] [Related]
17. TP53 R249S mutation, genetic variations in HBX and risk of hepatocellular carcinoma in The Gambia.
Gouas DA; Villar S; Ortiz-Cuaran S; Legros P; Ferro G; Kirk GD; Lesi OA; Mendy M; Bah E; Friesen MD; Groopman J; Chemin I; Hainaut P
Carcinogenesis; 2012 Jun; 33(6):1219-24. PubMed ID: 22759751
[TBL] [Abstract][Full Text] [Related]
18. Novel point and combo-mutations in the genome of hepatitis B virus-genotype D: characterization and impact on liver disease progression to hepatocellular carcinoma.
Datta S; Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Roy G; Das S; Das K; Gupta S; Basu K; Basu A; Datta S; Chowdhury A; Banerjee S
PLoS One; 2014; 9(10):e110012. PubMed ID: 25333524
[TBL] [Abstract][Full Text] [Related]
19. Comparison of hepatitis B X gene mutation between patients with hepatocellular carcinoma and patients with chronic hepatitis B.
Fan W; Shi B; Wei H; Du G; Song S
Virus Genes; 2011 Apr; 42(2):162-70. PubMed ID: 21161360
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism analyses of hepatitis B virus X gene in hepatocellular carcinoma patients from southern China.
Zhu P; Tan D; Peng Z; Liu F; Song L
Acta Biochim Biophys Sin (Shanghai); 2007 Apr; 39(4):265-72. PubMed ID: 17417681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]